Both in Pharmaceuticals
Liquidia vs AbCellera Biologics
Over the past year LQDA returned +67.3% and ABCL returned +126.8%; their daily moves had a correlation of 0.12.
LQDA +67.3% ABCL +126.8%Growth of $1, one year, split-adjusted
| Metric | LQDA | ABCL |
|---|---|---|
| Price | $42.20 | $12.18 |
| Market cap | $3.78B | $3.95B |
| Today | +0.84% | +9.53% |
| 1 month | +52.7% | −11.6% |
| 6 months | +5.2% | +161.4% |
| Year to date | +22.4% | +256.1% |
| 1 year | +73.2% | +119.5% |
| Revenue growth (YoY) | +1842.7% | −76.3% |
| Gross margin | 93.3% | 100.0% |
| Net margin | 43.5% | −1368.6% |
| P/E (TTM) | 27.3× | — |
| Price / sales | 8.4× | 59.6× |
| Net cash | $108.1M | $540.1M |
| Dividend yield | — | — |
| Volatility (60d) | 189.7% | 78.1% |
| Short % of float | 26.2% | 14.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).